Table 5
From the following article
Brazilian health biotech—fostering crosstalk between public and private sectors
Rahim Rezaie, Sarah E Frew, Stephen M Sammut, Maya R Maliakkal, Abdallah S Daar & Peter A Singer
Nature Biotechnology 26, 627 - 644 (2008)
doi:10.1038/nbt0608-627
Table 5. Intellectual property (IP) portfolios/marketing rights for the companies interviewed
| Company | Patent filed or issued |
|---|---|
| Aché Laboratórios Farmacêuticos | Thirty international patent applications, including 15 in Brazil. Acheflan (a topical anti-inflammatory) is patented in Brazil and application also submitted through patent cooperation treaty (PCT) in several countries. Shared IP with UNICAMP for a synthetic compound for diabetes. |
| Biogene | Ten new proteins patents (for diagnosis and vaccination against visceral leishmaniasis). Shares patent with Federal University of Pernambuco in Recife (for new diagnostic tests for leishmaniasis in animals). |
| Biolab Sanus Farmacêutica | Joint patent with COINFAR for Evasin (an endogenous vasopeptidase inhibitor) filed in Brazil. Others filed through Incrementha for solubilization methods of drugs. |
| BIOMM | Patents on expression and production of recombinant proteins granted in US, Europe, Russia, Israel, India and pending elsewhere. IP rights on technology platform to produce recombinant proteins in US, Europe and Asia. |
| COINFAR | Eight patents granted (until 2004) and 36 patent applications filed around the world, mainly US, EU, Japan, India, China. |
| Cryopraxis Criobiologia | One patent application in Brazil for an umbilical cord blood collection and shipping system. |
| FK Biotecnologia | One patent application through PCT and Brazilian patent office for cancer vaccine procedure. |
| Katal Biotecnológica | Two patent applications, including a joint patent application with a university for toxoplasmosis testing during pregnancy. |
| Nortec Química | Three patents filed in Brazil for production processes |
| Pele Nova Biotecnologia | One patent in Europe (through European Patent Office) in 2006 and applications filed in over 60 countries for BIOCURE (a rubber material used to treat skin lesions). Applications filed for uses of a VEGF protein with angiogenesis properties for various applications. |
| Recepta Biopharma | Worldwide licenses for patents related to four monoclonal antibodies held by the Ludwig Institute with worldwide rights. |
| Silvestre Labs | Shares US patent application with an American scientist for the development of filler agents, anti-wrinkle substance, wound healing dressings, cell manipulation technologies. |
